MedPath
TGA Approval

EVOCAIR MDI 125/25 fluticasone propionate 125 mcg/salmeterol (as xinafoate) 25 mcg inhalation pressurised aerosol can metered dose (with counter) (208667)

208667

EVOCAIR MDI 125/25 fluticasone propionate 125 mcg/salmeterol (as xinafoate) 25 mcg inhalation pressurised aerosol can metered dose (with counter)

Alphapharm Pty Ltd

May 7, 2014

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/60cc8a55397f3be6247cc69e0ad051a9.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/751c8d658407dced98387446f4e6cf18.pdf

Active Ingredients

fluticasone propionate

salmeterol xinafoate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

EVOCAIR MDI 125/25 fluticasone propionate 125 mcg/salmeterol (as xinafoate) 25 mcg inhalation pressurised aerosol can metered dose (with counter) (208667) - TGA 批准文号 | MedPath